Seeing Is Believing
KTTA is currently covered by 2 analysts with an average price target of $-5.15. This is a potential upside of $-6.61 (-452.74%) from yesterday's end of day stock price of $1.46.
Pasithea Therapeutics Corp's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of KTTA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 338 days.
Highest price target for KTTA is $9, Lowest price target is $8, average price target is $-5.15.
Most recent stock forecast was given by ELEMER PIROS from BENCHMARK on 10-Jul-2023. First documented stock forecast 15-Dec-2021.
Currently out of the existing stock ratings of KTTA, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$-3.06 (-60.47%)
$2
1 years 7 months 4 days ago
(10-Jul-2023)
0/2 (0%)
$-7.22 (-78.31%)
Buy
$2
$0.09 (4.71%)
$65
1 years 10 months 10 days ago
(03-Apr-2023)
1/2 (50%)
$-6 (-75.00%)
676
What is KTTA (Pasithea Therapeutics Corp) average time for price targets to be met?
Which analyst has the current highest performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?
Which analyst has the current lower performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?
Which analyst has the most public recommendations on KTTA (Pasithea Therapeutics Corp)?
Which analyst is the currently most bullish on KTTA (Pasithea Therapeutics Corp)?
Which analyst is the currently most reserved on KTTA (Pasithea Therapeutics Corp)?